메뉴 건너뛰기




Volumn 11, Issue 6, 1993, Pages 1179-1188

Pharmacodynamics of prolonged oral etoposide in patients with advanced non-small-cell lung cancer

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE;

EID: 0027153911     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1993.11.6.1179     Document Type: Article
Times cited : (49)

References (32)
  • 2
    • 0024417601 scopus 로고
    • A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer
    • Slevin ML, Clark PI, Joel SP, et al: A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer. J Clin Oncol 7:1333-1340, 1989
    • (1989) J Clin Oncol , vol.7 , pp. 1333-1340
    • Slevin, M.L.1    Clark, P.I.2    Joel, S.P.3
  • 3
    • 0001184894 scopus 로고
    • A pharmacokinetic hypothesis for the clinical efficacy of etoposide in small cell lung cancer
    • abstr
    • Clark PI, Joel SP, Slevin ML: A pharmacokinetic hypothesis for the clinical efficacy of etoposide in small cell lung cancer. Proc Am Soc Clin Oncol 8:66, 1989 (abstr)
    • (1989) Proc Am Soc Clin Oncol , vol.8 , pp. 66
    • Clark, P.I.1    Joel, S.P.2    Slevin, M.L.3
  • 4
    • 0024505316 scopus 로고
    • Chronic daily administration of oral etoposide - A phase I trial
    • Hainsworth JD, Johnson DH, Frazier SR, et al: Chronic daily administration of oral etoposide - A phase I trial. J Clin Oncol 7:396-401, 1989
    • (1989) J Clin Oncol , vol.7 , pp. 396-401
    • Hainsworth, J.D.1    Johnson, D.H.2    Frazier, S.R.3
  • 5
    • 0025130651 scopus 로고
    • Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: A phase II trial
    • Johnson DH, Greco FA, Strupp J: Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: A phase II trial. J Clin Oncol 8:1613-1617, 1940
    • (1940) J Clin Oncol , vol.8 , pp. 1613-1617
    • Johnson, D.H.1    Greco, F.A.2    Strupp, J.3
  • 6
    • 0025162020 scopus 로고
    • Phase II trial of daily oral VP-16 in refractory small cell lung cancer: A Hoosier Oncology Group study
    • Einhorn LW, Pennington K, McClean J: Phase II trial of daily oral VP-16 in refractory small cell lung cancer: A Hoosier Oncology Group study. Semin Oncol 17:32-35, 1990
    • (1990) Semin Oncol , vol.17 , pp. 32-35
    • Einhorn, L.W.1    Pennington, K.2    McClean, J.3
  • 7
    • 0024371468 scopus 로고
    • A phase II study of oral etoposide in elderly patients with small cell lung cancer
    • Smit EF, Carney DN, Harford P, et al: A phase II study of oral etoposide in elderly patients with small cell lung cancer. Thorax 44:631-633, 1989
    • (1989) Thorax , vol.44 , pp. 631-633
    • Smit, E.F.1    Carney, D.N.2    Harford, P.3
  • 8
    • 0001690080 scopus 로고
    • Prolonged administration of single-agent oral etoposide in patients with untreated small cell lung cancer
    • abstr
    • Clark PI, Cottier B, Joel SP, et al: Prolonged administration of single-agent oral etoposide in patients with untreated small cell lung cancer. Proc Am Soc Clin Oncol 9:226, 1990 (abstr)
    • (1990) Proc Am Soc Clin Oncol , vol.9 , pp. 226
    • Clark, P.I.1    Cottier, B.2    Joel, S.P.3
  • 9
    • 0025141586 scopus 로고
    • Phase II study of daily oral etoposide in refractory germ cell tumors
    • Miller JC, Einhorn LH: Phase II study of daily oral etoposide in refractory germ cell tumors. Semin Oncol 17:36-39, 1990
    • (1990) Semin Oncol , vol.17 , pp. 36-39
    • Miller, J.C.1    Einhorn, L.H.2
  • 10
    • 0025145356 scopus 로고
    • Chronic daily administration of oral etoposide in refractory lymphoma
    • Hainsworth JD, Johnson DH, Frazier SR, et al: Chronic daily administration of oral etoposide in refractory lymphoma. Eur J Cancer 26:818-821, 1990
    • (1990) Eur J Cancer , vol.26 , pp. 818-821
    • Hainsworth, J.D.1    Johnson, D.H.2    Frazier, S.R.3
  • 11
    • 2642713777 scopus 로고
    • Phase II trial of daily oral etoposide in patients with surgically unresectable non-small cell lung cancer
    • abstr
    • Saxman S, Logie K, Stephens D, et al: Phase II trial of daily oral etoposide in patients with surgically unresectable non-small cell lung cancer. Proc Am Soc Clin Oncol 9:238, 1990 (abstr)
    • (1990) Proc Am Soc Clin Oncol , vol.9 , pp. 238
    • Saxman, S.1    Logie, K.2    Stephens, D.3
  • 12
    • 0026547005 scopus 로고
    • Prolonged administration of oral etoposide in non-small cell lung cancer: A phase II trial
    • Waits TM, Johnson DH, Hainsworth JD, et al: Prolonged administration of oral etoposide in non-small cell lung cancer: A phase II trial. J Clin Oncol 10:292-296, 1992
    • (1992) J Clin Oncol , vol.10 , pp. 292-296
    • Waits, T.M.1    Johnson, D.H.2    Hainsworth, J.D.3
  • 13
    • 84910968324 scopus 로고
    • Cisplatin (P) & prolonged administration of oral etoposide (E) in extensive small cell lung cancer (ESCLC) patients (PT): A phase II trial
    • abstr
    • Murphy PB, Hainsworth JD, Greco FA, et al: Cisplatin (P) & prolonged administration of oral etoposide (E) in extensive small cell lung cancer (ESCLC) patients (PT): A phase II trial. Proc Am Soc Clin Oncol 10:257, 1991 (abstr)
    • (1991) Proc Am Soc Clin Oncol , vol.10 , pp. 257
    • Murphy, P.B.1    Hainsworth, J.D.2    Greco, F.A.3
  • 14
    • 84910968324 scopus 로고
    • Carboplatin (CBDCA) plus prolonged administration of oral etoposide (E) in the treatment of non-small cell lung cancer (NSCLC): A phase I/II trial
    • abstr
    • Walls J, Devore R, Hainsworth JD, et al: Carboplatin (CBDCA) plus prolonged administration of oral etoposide (E) in the treatment of non-small cell lung cancer (NSCLC): A phase I/II trial. Proc Am Soc Clin Oncol 10:257, 1991 (abstr)
    • (1991) Proc Am Soc Clin Oncol , vol.10 , pp. 257
    • Walls, J.1    Devore, R.2    Hainsworth, J.D.3
  • 16
    • 0024412440 scopus 로고
    • The effect of dose on the bioavailability of oral etoposide: Confirmation of a clinically relevant observation
    • Slevin ML, Joel SP, Whomsley R, et al: The effect of dose on the bioavailability of oral etoposide: Confirmation of a clinically relevant observation. Cancer Chemother Pharmacol 24:329-331, 1989
    • (1989) Cancer Chemother Pharmacol , vol.24 , pp. 329-331
    • Slevin, M.L.1    Joel, S.P.2    Whomsley, R.3
  • 17
    • 1542302306 scopus 로고
    • Improved bioavailability (BA) with low dose oral (PO) etoposide (E)
    • abstr
    • Hande KR, Bennett RB, Krozley MG, et al: Improved bioavailability (BA) with low dose oral (PO) etoposide (E). Proc Am Soc Clin Oncol 10:96, 1991 (abstr)
    • (1991) Proc Am Soc Clin Oncol , vol.10 , pp. 96
    • Hande, K.R.1    Bennett, R.B.2    Krozley, M.G.3
  • 18
    • 0001349582 scopus 로고
    • The bioavailability of oral etoposide during prolonged administration and development of a limited sampling strategy for the estimation of AUC after an oral dose
    • abstr
    • Joel SP, Dolega-Ossowksi E, Jones K, et al: The bioavailability of oral etoposide during prolonged administration and development of a limited sampling strategy for the estimation of AUC after an oral dose. Proc Am Assoc Cancer Res 32:178, 1991 (abstr)
    • (1991) Proc Am Assoc Cancer Res , vol.32 , pp. 178
    • Joel, S.P.1    Dolega-Ossowksi, E.2    Jones, K.3
  • 19
    • 0022414303 scopus 로고
    • The effect of food and concurrent chemotherapy on the bioavailability of oral etoposide
    • Harvey VJ, Slevin ME, Joel SP, et al: The effect of food and concurrent chemotherapy on the bioavailability of oral etoposide. Br J Cancer 52:363-367, 1985
    • (1985) Br J Cancer , vol.52 , pp. 363-367
    • Harvey, V.J.1    Slevin, M.E.2    Joel, S.P.3
  • 22
    • 0019785890 scopus 로고
    • Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models
    • Holford NHG, Sheiner LB: Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet 6:429-453, 1981
    • (1981) Clin Pharmacokinet , vol.6 , pp. 429-453
    • Holford, N.H.G.1    Sheiner, L.B.2
  • 25
    • 0025080582 scopus 로고
    • Low-dose oral etoposide: A new role for an old drug?
    • editorial
    • Slevin ML: Low-dose oral etoposide: A new role for an old drug? J Clin Oncol 8:1607-1609, 1990 (editorial)
    • (1990) J Clin Oncol , vol.8 , pp. 1607-1609
    • Slevin, M.L.1
  • 27
    • 0025194085 scopus 로고
    • Is chemotherapy for metastatic non small cell lung cancer 'worth if?
    • editorial
    • Ruckdeschel JC: Is chemotherapy for metastatic non small cell lung cancer 'worth if? J Clin Oncol 8:1293-1295, 1990 (editorial)
    • (1990) J Clin Oncol , vol.8 , pp. 1293-1295
    • Ruckdeschel, J.C.1
  • 28
    • 0025744506 scopus 로고
    • Pharmacologically based dosing of etoposide: A means of safely increasing dose intensity
    • Ratain MJ, Mick R, Schilsky RL, et al: Pharmacologically based dosing of etoposide: A means of safely increasing dose intensity. J Clin Oncol 9:1480-1486, 1991
    • (1991) J Clin Oncol , vol.9 , pp. 1480-1486
    • Ratain, M.J.1    Mick, R.2    Schilsky, R.L.3
  • 30
    • 0026004507 scopus 로고
    • Modeling interpatient pharmacodynamic variability of etoposide
    • Mick R, Ratain MJ: Modeling interpatient pharmacodynamic variability of etoposide. J Natl Cancer Inst 83:1560-1564, 1991
    • (1991) J Natl Cancer Inst , vol.83 , pp. 1560-1564
    • Mick, R.1    Ratain, M.J.2
  • 31
    • 0026079516 scopus 로고
    • Pharmacokinetic and pharmacodynamic analysis of fluorouracil during 72-hour continuous infusion with and without dipyridamole
    • Trump DL, Egorin MJ, Forrest A, et al: Pharmacokinetic and pharmacodynamic analysis of fluorouracil during 72-hour continuous infusion with and without dipyridamole. J Clin Oncol 9:2027-2035, 1991
    • (1991) J Clin Oncol , vol.9 , pp. 2027-2035
    • Trump, D.L.1    Egorin, M.J.2    Forrest, A.3
  • 32
    • 0023031031 scopus 로고
    • Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy
    • O'Connel JP, Kris MG, Grall RJ, et al: Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy. J Clin Oncol 4:1604-1614, 1986
    • (1986) J Clin Oncol , vol.4 , pp. 1604-1614
    • O'Connel, J.P.1    Kris, M.G.2    Grall, R.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.